Login / Signup

Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease.

Ryan M RivosecchiLara M GroetzingerTaylor J Miller
Published in: The Annals of pharmacotherapy (2018)
Keyphrases
  • chronic kidney disease
  • atrial fibrillation
  • venous thromboembolism
  • end stage renal disease
  • direct oral anticoagulants
  • oral anticoagulants
  • peritoneal dialysis